We are live on ! Find out more
OPTN

OptiNose

Delisted

OPTN was delisted on the 20th of May, 2025.

77 hedge funds and large institutions have $199M invested in OptiNose in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 16

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

5% more funds holding

Funds holding: 7377 (+4)

5% more capital invested

Capital invested by funds: $189M → $199M (+$10.1M)

0.22% more ownership

Funds ownership: 4.35%4.57% (+0.22%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
77
Holders Change
+4
Holders Change %
+5.48%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
29
Reduced
16
Closed
9
Calls
Puts
Net Calls
Net Calls Change

OPTN Hedge Fund Activity: Q3 2019 in Review

77 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q3 2019, worth a combined $199M — up 5.3% from $189M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new OPTN positions and 9 closed out — a net gain of 4 holders — while 29 added to existing stakes and 16 trimmed.

The largest buyer was Tamarack Advisers, opening a new position worth an estimated $4.49M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.22M sold.

  • 77 institutional investors held OptiNose (OPTN) as of Q3 2019, up from 73 in Q2 2019.
  • Funds reported $199M of OptiNose stock for Q3 2019, up 5.3% quarter-over-quarter.
  • 13 funds opened new OptiNose positions in Q3 2019 and 9 closed out, a net change of +4 holders.
  • The largest OptiNose buyer in Q3 2019 was Tamarack Advisers, an estimated $4.49M added.
  • The largest OptiNose seller in Q3 2019 was Broadfin Capital, an estimated $4.22M sold.

Based on aggregated 13F filings for Q3 2019.